Can Liu

5.2k total citations · 2 hit papers
83 papers, 4.1k citations indexed

About

Can Liu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Can Liu has authored 83 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 25 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Can Liu's work include MicroRNA in disease regulation (16 papers), Cancer-related molecular mechanisms research (12 papers) and Circular RNAs in diseases (12 papers). Can Liu is often cited by papers focused on MicroRNA in disease regulation (16 papers), Cancer-related molecular mechanisms research (12 papers) and Circular RNAs in diseases (12 papers). Can Liu collaborates with scholars based in China, United States and Pakistan. Can Liu's co-authors include Dean G. Tang, Collene Jeter, Tammy Calhoun‐Davis, Bigang Liu, Xin Chen, Lubna Patrawala, Kevin Kelnar, Jason F. Wiggins, David T. Brown and Sofia Honorio and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Can Liu

77 papers receiving 4.0k citations

Hit Papers

The microRNA miR-34a inhibits prostate cancer stem cells ... 2011 2026 2016 2021 2011 2020 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Can Liu China 26 3.0k 1.9k 955 365 288 83 4.1k
Sofia Avnet Italy 36 2.2k 0.7× 1.1k 0.6× 962 1.0× 545 1.5× 551 1.9× 107 3.9k
Ke Xu China 38 2.1k 0.7× 1.1k 0.6× 792 0.8× 307 0.8× 540 1.9× 145 4.2k
Wantao Chen China 36 2.4k 0.8× 1.2k 0.7× 1.0k 1.0× 362 1.0× 322 1.1× 136 4.0k
Merja Perälä Finland 34 2.1k 0.7× 1.3k 0.7× 488 0.5× 289 0.8× 183 0.6× 62 3.6k
Gang Yin China 28 3.2k 1.1× 1.6k 0.9× 863 0.9× 412 1.1× 111 0.4× 100 4.6k
Hu Chen China 33 2.0k 0.7× 953 0.5× 939 1.0× 218 0.6× 209 0.7× 176 3.7k
Qiwei Yang China 28 1.9k 0.7× 1.0k 0.5× 544 0.6× 255 0.7× 456 1.6× 111 3.3k

Countries citing papers authored by Can Liu

Since Specialization
Citations

This map shows the geographic impact of Can Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Liu more than expected).

Fields of papers citing papers by Can Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Can Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Liu. The network helps show where Can Liu may publish in the future.

Co-authorship network of co-authors of Can Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Can Liu. A scholar is included among the top collaborators of Can Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Can Liu. Can Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xingkai, Dong Dai, Siqi Zhang, et al.. (2025). A Cyclic Peptide‐Based Radiotheranostic Agent for Urokinase‐Type Plasminogen Activator in Tumors. Chemistry - A European Journal. 31(28). e202500479–e202500479. 1 indexed citations
3.
Yuan, Lin, Yanyan Wang, Lei Dong, et al.. (2025). miRNAs Associated with Axillary Lymph Node Metastasis in Breast Cancer: A Systematic Review and Meta-Analysis. Annals of Surgical Oncology.
4.
Liu, Can, et al.. (2024). STUB1 is acetylated by KAT5 and alleviates myocardial ischemia-reperfusion injury through LATS2-YAP-β-catenin axis. Communications Biology. 7(1). 396–396. 9 indexed citations
5.
Guan, Pengfei, Lei Fan, Qinfeng Yang, et al.. (2024). M2 microglia-derived exosome-loaded electroconductive hydrogel for enhancing neurological recovery after spinal cord injury. Journal of Nanobiotechnology. 22(1). 8–8. 36 indexed citations
6.
Preston‐Hurlburt, Paula, Pamela Clark, Peter S. Linsley, et al.. (2024). Teplizumab induces persistent changes in the antigen-specific repertoire in individuals at risk for type 1 diabetes. Journal of Clinical Investigation. 134(18). 17 indexed citations
7.
Liu, Can, et al.. (2024). Activation of AMPK inhibits cervical cancer growth by hyperacetylation of H3K9 through PCAF. Cell Communication and Signaling. 22(1). 306–306. 7 indexed citations
8.
Chen, Feng, Changsheng He, Xueping Li, et al.. (2023). A universal all-in-one RPA-Cas12a strategy with de novo autodesigner and its application in on-site ultrasensitive detection of DNA and RNA viruses. Biosensors and Bioelectronics. 239. 115609–115609. 34 indexed citations
9.
Xia, Cong, Can Liu, Shuangyi Ren, et al.. (2023). Potassium channels, tumorigenesis and targeted drugs. Biomedicine & Pharmacotherapy. 162. 114673–114673. 14 indexed citations
10.
Wu, Jinna, et al.. (2023). The role of gut microbiota and drug interactions in the development of colorectal cancer. Frontiers in Pharmacology. 14. 7 indexed citations
11.
Wang, Ya‐Wen, et al.. (2023). An angiogenesis-related lncRNA signature predicts the immune microenvironment and prognosis of breast cancer. Aging. 15(15). 7616–7636. 6 indexed citations
12.
Liu, Can, et al.. (2023). Hsa_circ_0000078 Regulates miR-205-5p/EREG Pathway to Inhibit Cervical Cancer Progression. Molecular Biotechnology. 65(9). 1453–1464. 3 indexed citations
13.
Wang, Yanyan, Can Liu, Jian Ji, et al.. (2021). Heat Shock Protein 90α in Nipple Discharge as a Potential Tumor Marker for Breast Cancer. The Chinese Journal of Physiology. 64(5). 251–256. 4 indexed citations
14.
Liu, Can, et al.. (2017). Eg5 Overexpression Is Predictive of Poor Prognosis in Hepatocellular Carcinoma Patients. Disease Markers. 2017. 1–9. 22 indexed citations
15.
Liu, Can, et al.. (2015). Research Advances in the Treatment of Melanoma by Treat Melanoma. Current Topics in Medicinal Chemistry. 16(2). 242–250. 3 indexed citations
16.
Jin, Min, Tao Zhang, Can Liu, et al.. (2014). miRNA-128 Suppresses Prostate Cancer by Inhibiting BMI-1 to Inhibit Tumor-Initiating Cells. Cancer Research. 74(15). 4183–4195. 114 indexed citations
17.
Liu, Can, Dongbo Liu, Guoxian Long, et al.. (2013). Specific targeting of angiogenesis in lung cancer with RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a 4.7T magnetic resonance scanner. Chinese Medical Journal. 126(12). 2242–2247. 9 indexed citations
18.
Liu, Can, Kevin Kelnar, Alexander V. Vlassov, et al.. (2012). Distinct microRNA Expression Profiles in Prostate Cancer Stem/Progenitor Cells and Tumor-Suppressive Functions of let-7. Cancer Research. 72(13). 3393–3404. 157 indexed citations
19.
Chen, Tianbin, Qicai Liu, Ling Jiang, Can Liu, & Qishui Ou. (2012). Mitochondrial COX2 G7598A Mutation May Have a Modifying Role in the Phenotypic Manifestation of Aminoglycoside Antibiotic-Induced Deafness Associated with 12S rRNA A1555G Mutation in a Han Chinese Pedigree. Genetic Testing and Molecular Biomarkers. 17(2). 122–130. 10 indexed citations
20.
Tang, Lin, Xiaoxia Lei, Guangming Zeng, et al.. (2012). Optical detection of NADH based on biocatalytic growth of Au–Ag core–shell nanoparticles. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 99. 390–393. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026